|
Volumn 3, Issue 8, 2004, Pages 776-777
|
PI3K: Missense mutation motivates malignancy
|
Author keywords
Breast cancer; Mutation; Oncogene; PI3 Kinase; PIK3CA
|
Indexed keywords
DNA;
ESTROGEN RECEPTOR;
GENOMIC DNA;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
PROTEIN 110ALPHA;
PROTEIN KINASE B;
PROTEIN P110;
PROTEIN TYROSINE KINASE;
TAMOXIFEN;
UNCLASSIFIED DRUG;
PIK3CA PROTEIN, HUMAN;
TUMOR MARKER;
ALLELE;
APOPTOSIS;
BREAST CANCER;
CANCER CELL CULTURE;
CANCER GROWTH;
CANCER PATIENT;
CANCER RISK;
CANCER STAGING;
CARCINOGENESIS;
CELL GROWTH;
CELL MOTILITY;
CELL PROLIFERATION;
COLON CANCER;
COLORECTAL TUMOR;
DNA REPAIR;
DNA SEQUENCE;
ENZYME ACTIVE SITE;
EXON;
GENE;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
METASTASIS;
MISSENSE MUTATION;
NOTE;
ONCOGENE;
ONCOGENE NEU;
PHYSICIAN;
PROGNOSIS;
RISK FACTOR;
SAMPLE;
SOMATIC MUTATION;
TUMOR SUPPRESSOR GENE;
BREAST TUMOR;
DISEASE COURSE;
ENZYMOLOGY;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
METABOLISM;
1-PHOSPHATIDYLINOSITOL 3-KINASE;
BREAST NEOPLASMS;
DISEASE PROGRESSION;
FEMALE;
GENE EXPRESSION REGULATION, ENZYMOLOGIC;
HUMANS;
MUTATION, MISSENSE;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 16644374314
PISSN: 15384047
EISSN: 15558576
Source Type: Journal
DOI: 10.4161/cbt.3.8.1031 Document Type: Note |
Times cited : (4)
|
References (9)
|